The DOI matches its Crossref record.
Systematic LC‐MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought‐out chromatography
Abstract
This treatise summarizes the underlying principle and the road map for systematic LC‐MS/MS bioanalytical method development. The three themes that have recently emerged as central to building quality during method development—phospholipids, incurred sample and sound chromatographic considerations—are the main focus of this article. In order to reduce the bioanalytical risk associated with plasma phospholipids, a dual approach involving extraction and chromatography is recommended. The use of incurred sample during method development is essential to avoid interference arising from drug‐related components. This is different from the current practice of incurred sample reanalysis, which tests reproducibility during method application. LC column/mobile phase optimization is needed to achieve appropriate peak shape, sensitivity and the separation of the analyte from interfering metabolites and phospholipids. Related to sound chromatographic considerations, we lay out facts and myths related to UPLC, vis‐à‐vis HPLC. Incorporation of quality during method development avoids the costly experience of finding out by chance about the invalidity of a method after it has been used in support of a number of pivotal clinical and non‐clinical studies. To this end, we put forth an outline of a protocol for a systematic LC‐MS/MS bioanalytical method development. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lipid analysis by thin-layer chromatography—A review of the current state
Fuchs, B., Süß, R., Teuber, K., Eibisch, M., & Schiller, J. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.11.066 · Cited by 377
Bylda, C., Thiele, R., Kobold, U., & Volmer, D. A. (2014) · The Analyst · doi:10.1039/c4an00094c · Cited by 271
Quality requirements for quantitative clinical chemistry proteomics
(2014) · Translational Proteomics · doi:10.1016/j.trprot.2013.10.001 · Cited by 11
Metadata
- Authors
- Jemal, M., Ouyang, Z., & Xia, Y.
- Venue
- Biomedical Chromatography
- Publisher
- Wiley
- Published
- 2009-12-16
- Volume
- 24
- Issue
- 1
- Pages
- 2-19
- ISSN
- 0269-3879 (ISSN-L)
- 1099-0801
- OpenAlex
- W2141387425
- Cited by
- 192
- References
- 0
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic LC‐MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought‐out chromatography. https://app.cochat.ai/papers/10.1002/bmc.1373
- The paper
- Jemal, M., Ouyang, Z., & Xia, Y. (2010). Systematic LC‐MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought‐out chromatography. Biomedical Chromatography. https://doi.org/10.1002/bmc.1373
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.